COVID-19 and Alzheimer’s disease in the ADNI cohort
INTRODUCTION: There is growing evidence that COVID-19 infection in older adults increases the risk of diagnosis of Alzheimer’s disease and accelerates cognitive decline. We hypothesized that participants reporting COVID-19 infection would have greater cognitive and functional decline and greater occurrence of neuropsychiatric symptoms after COVID-19 infection in comparison to uninfected matched controls. METHODS This secondary data analysis from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort examined participants with and without self-reported history of COVID-19 infection comparing visits before and after infection. RESULTS The 16 participants included in the COVID-19 cohort and the 32 controls, had similar changes in cognitive, functionality and behavioral measures between study visits. CONCLUSIONS While there is evidence that COVID-19 infection increases the risk for depression, cognitive changes and conversion to dementia, this examination of a well characterized cohort of at risk and cognitive impaired individuals did not find evidence for the impact of COVID-19 after infection.
Authors
- Warren D. Taylor (ORCID: https://orcid.org/0000-0002-9975-3082)
- Patricia Andrews (ORCID: https://orcid.org/0000-0002-9348-3632)
- Ke Xu (ORCID: https://orcid.org/0000-0002-6101-3257)
- Paul Newhouse
- Brian Boyd
- Kathleen Mather
- Hakmook Kang
- Kiara Baker
Institutions
- University of North Carolina at Chapel Hill (US)
- Yale University (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-20
- DOI
- https://doi.org/10.21203/rs.3.rs-11089141/v1
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- preprint